Gyre COO sells shares after option exercises
GYRE Therapeutics Chief Operating Officer Ye Weiguo reported a small exercise-and-sell sequence in common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
GYRE Therapeutics Chief Operating Officer Ye Weiguo reported a small exercise-and-sell sequence in common stock. On May 18–19, he exercised stock options covering 9,320 shares of common stock at an exercise price of $0.75 per share and sold the same number of shares in open-market transactions at weighted average prices around $6.37 per share, within disclosed price ranges. Following these transactions, he directly holds 700,000 shares of common stock.
Insider Trade Summary
Exercise and Sale: 9,320 shares ($52K approx. pre-tax spread)
Exercise and Sale
6 txns
Insider
Ye Weiguo
Role
Chief Operating Officer
Sold
9,320 shs ($59K)
Approx. gross sale proceeds
$59K
Approx. exercise cost
$7K
Approx. pre-tax spread
$52K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 9,120 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,120 | $0.75 | $7K |
| Sale | Common Stock | 9,120 | $6.37 | $58K |
| Exercise | Stock Option (Right to Buy) | 200 | $0.00 | $0.00 |
| Exercise | Common Stock | 200 | $0.75 | $150.00 |
| Sale | Common Stock | 200 | $6.62 | $1K |
Holdings After Transaction:
Stock Option (Right to Buy) — 927,115 contracts (Direct);
Common Stock — 700,000 shares (Direct)
Footnotes (3)
- F1. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.6102 to $6.6215. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F2. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $6.3002 to $6.4119. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3. These options are vested in full.
Key Figures
Shares sold: 9,320 shares
Weighted avg sale price May 19: $6.37 per share
Weighted avg sale price May 18: $6.62 per share
+4 more
7 metrics
Shares sold
9,320 shares
Common stock open-market sales on May 18–19
Weighted avg sale price May 19
<money>$6.37</money> per share
Common stock sales with prices from $6.3002 to $6.4119
Weighted avg sale price May 18
<money>$6.62</money> per share
Common stock sales with prices from $6.6102 to $6.6215
Option exercise price
<money>$0.75</money> per share
Stock option exercises into common stock
Common shares held after
700,000 shares
Directly owned GYRE common stock after transactions
Options exercised
9,320 options
Stock Option (Right to Buy) converted into common stock
Option expiration date
<date>2030-10-31</date>
Expiration for the Stock Option (Right to Buy) series
Key Terms
open-market sale, Stock Option (Right to Buy), weighted average sale price, derivative security
4 terms
open-market sale financial
"transaction_action: "open-market sale" for common stock sales"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" in derivative entries"
weighted average sale price financial
"The price reported represents the weighted average sale price per share."
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did GYRE COO Ye Weiguo report?
Ye Weiguo reported exercising stock options for 9,320 GYRE common shares and selling the same number in open-market trades. These transactions occurred on May 18–19 and are recorded as option exercises followed by open-market sales.
What was the stock option exercise price in the GYRE Form 4?
The Form 4 shows stock options exercised at an exercise price of $0.75 per underlying GYRE common share. Each of the option exercises on May 18 and May 19 covered 200 and 9,120 shares respectively at this same $0.75 per share exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates